Find More Contacts for Onconova Therapeutics
Protected Content
CFO, COO
Non-Management, Executive Finance, Management, Operations
3 emails found 2 phone numbers found
View contacts for Onconova Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@onconova.us
  • Phone Number 2677593681

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important

in cancer cells, while causing minimal damage to normal cells. It has three product candidates in clinical trials and six active pre-clinical programs.

Onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.

Lists Featuring This Company

Biotechnology Public Companies With Fewer Than 1000 Employees
1,947 Number of Organizations • $309.9B Total Funding Amount • 9,085 Number of Investors
Pennsylvania Public Companies
243 Number of Organizations • $60.6B Total Funding Amount • 461 Number of Investors
Northeastern US Companies With Fewer Than 1000 Employees (Top 10K)
9,969 Number of Organizations • $611.2B Total Funding Amount • 60,617 Number of Investors
Great Lakes Companies (Top 10K)
9,805 Number of Organizations • $659.9B Total Funding Amount • 29,352 Number of Investors

Frequently Asked Questions

Where is Onconova Therapeutics's headquarters? Onconova Therapeutics is located in Newtown, Pennsylvania, United States.Who invested in Onconova Therapeutics? Onconova Therapeutics has 3 investors including Lincoln Park Capital Fund and Sio Capital Management.How much funding has Onconova Therapeutics raised to date? Onconova Therapeutics has raised .When was the last funding round for Onconova Therapeutics? Onconova Therapeutics closed its last funding round on Sep 24, 2021 from a Post-IPO Equity round.Who are Onconova Therapeutics's competitors? Alternatives and possible competitors to Onconova Therapeutics may include CytokineticsAgile Therapeutics, and Milestone Pharmaceuticals.